Autologous hematopoietic cell transplantation for the treatment of relapsed/refractory pediatric, adolescent, and young adult Hodgkin lymphoma: a single institutional experience-Reference-Cited by-同舟云学术

Autologous hematopoietic cell transplantation for the treatment of relapsed/refractory pediatric, adolescent, and young adult Hodgkin lymphoma: a single institutional experience

Published:2020-04-09 Issue:7 Volume:55 Page:1357-1366
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Talleur Aimee C.^ORCID,Flerlage Jamie E.,Shook David R.,Chilsen Abigail M.,Hudson Melissa M.,Cheng Cheng,Huang Sujuan,Triplett Brandon M.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-020-0879-4.pdf

Reference38 articles.

1. Terezakis SA, Metzger ML, Hodgson DC, Schwartz CL, Advani R, Flowers CR, et al. ACR appropriateness criteria pediatric Hodgkin Lymphoma. Pediatr Blood Cancer. 2014;61:1305–12.

2. Hoppe BS, Flampouri S, Zaiden R, Slayton W, Sandler E, Ozdemir S, et al. Involved-node proton therapy in combined modality therapy for Hodgkin Lymphoma: results of a phase 2 study. Int J Radiat Oncol Biol Phys. 2014;89:1053–9.

3. Wolden SL, Chen L, Kelly KM, Herzog P, Gilchrist GS, Thomson J, et al. Long-term results of CCG 5942: a randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin’s lymphoma—a report from the Children’s Oncology Group. J Clin Oncol. 2012;30:3174–80.

4. Mauz-Korholz C, Metzger ML, Kelly KM, Schwartz CL, Castellanos ME, Dieckmann K, et al. Pediatric Hodgkin Lymphoma. J Clin Oncol. 2015;33:2975–85.

5. Metzger ML, Hudson MM, Krasin MJ, Wu J, Kaste SC, Kun LE, et al. Initial response to salvage therapy determines prognosis in relapsed pediatric Hodgkin lymphoma patients. Cancer. 2010;116:4376–84.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Late morbidity and mortality after autologous blood or marrow transplantation for lymphoma in children, adolescents and young adults—a BMTSS report;Leukemia;2024-02-19

2. Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma;Blood Advances;2023-07-03

3. Outcome and toxicity of ifosfamide, carboplatin, and etoposide versus gemcitabine and vinorelbine regimen for pediatric patients with relapsed or refractory Hodgkin’s lymphoma;Frontiers in Oncology;2023-06-27

4. Pediatric Autologous Hematopoietic Stem Cell Transplantation: Safety, Efficacy, and Patient Outcomes. Literature Review;Pediatric Health, Medicine and Therapeutics;2023-05

5. A Cure Rate Survival Model after Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma Patients;MIDDLE EAST J CANCER;2022